scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's lead product is Furoscix. Furoscix consist... scPharmaceuticals Inc is a pharmaceutical company. Its pipeline includes products in various stages of clinical and non-clinical development. It focuses on pharmaceutical products in the cardiovascular and infectious disease therapeutic areas. The company's lead product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure. Show more
scPharmaceuticals received $75 million through a combination of debt and royalty financings at close, with access to an additional $50 million The term loan refinances existing debt principal;...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.325 | 6.36630754163 | 5.105 | 5.65 | 5.105 | 357728 | 5.45706255 | CS |
4 | 0.01 | 0.184501845018 | 5.42 | 5.65 | 4.86 | 261210 | 5.24388634 | CS |
12 | 1.05 | 23.9726027397 | 4.38 | 5.65 | 4 | 259821 | 4.87488818 | CS |
26 | -0.07 | -1.27272727273 | 5.5 | 5.7 | 3.24 | 243916 | 4.63188528 | CS |
52 | -1.67 | -23.5211267606 | 7.1 | 7.55 | 3.24 | 268604 | 5.17170022 | CS |
156 | -0.51 | -8.58585858586 | 5.94 | 12.75 | 3.24 | 251399 | 6.74890684 | CS |
260 | -1.11 | -16.9724770642 | 6.54 | 12.75 | 3.24 | 187621 | 6.77435026 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.